Session Details
[ES-13]20 Years of KOUTAISHOKUNIN: Antibody Discovery Using the HuCAL® Library
Fri. Dec 4, 2026 3:15 PM - 3:45 PM JST
Fri. Dec 4, 2026 6:15 AM - 6:45 AM UTC
Fri. Dec 4, 2026 6:15 AM - 6:45 AM UTC
Room 23 (Exhibition Hall Open Stage)
GeneFrontier Corporation
GeneFrontier has been providing its phage display-based antibody generation service, KOUTAISHOKUNIN®, for more than 20 years. By combining the HuCAL® human antibody library with proprietary selection technologies, we have successfully generated highly specific antibodies capable of distinguishing post-translational modifications such as phosphorylation, subtle differences of only a few amino acids, and even conformational epitopes.
In this seminar, we will present the practical aspects of antibody discovery developed through more than two decades of experience. Topics will include the technical principles behind KOUTAISHOKUNIN, representative antibody generation case studies, and applications in drug discovery research and diagnostics. We will also discuss the technical considerations and know-how that contribute to the successful generation of highly specific antibodies against challenging targets.
In this seminar, we will present the practical aspects of antibody discovery developed through more than two decades of experience. Topics will include the technical principles behind KOUTAISHOKUNIN, representative antibody generation case studies, and applications in drug discovery research and diagnostics. We will also discuss the technical considerations and know-how that contribute to the successful generation of highly specific antibodies against challenging targets.
[ES-13-01]20 Years of KOUTAISHOKUNIN: Antibody Discovery Using the HuCAL® Library
Takashi Ebihara (GeneFrontier Corporation)
